These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6374403

  • 1. Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Hvizdala E, Berry DH, Chen T, Dyment PG, Kim TH, Steuber CP, Sullivan MP.
    Med Pediatr Oncol; 1984; 12(3):173-7. PubMed ID: 6374403
    [Abstract] [Full Text] [Related]

  • 2. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.
    Sullivan MP, Chen T, Dyment PG, Hvizdala E, Steuber CP.
    Blood; 1982 Oct; 60(4):948-58. PubMed ID: 6956376
    [Abstract] [Full Text] [Related]

  • 3. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B.
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [Abstract] [Full Text] [Related]

  • 4. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Pullen J, Boyett J, Shuster J, Crist W, Land V, Frankel L, Iyer R, Backstrom L, van Eys J, Harris M.
    J Clin Oncol; 1993 May; 11(5):839-49. PubMed ID: 8487048
    [Abstract] [Full Text] [Related]

  • 5. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
    Bleyer WA, Coccia PF, Sather HN, Level C, Lukens J, Niebrugge DJ, Siegel S, Littman PS, Leikin SL, Miller DR.
    J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
    [Abstract] [Full Text] [Related]

  • 6. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Lauer SJ, Camitta BM, Leventhal BG, Mahoney DH, Shuster JJ, Adair S, Casper JT, Civin CI, Graham M, Kiefer G.
    Cancer; 1993 May 01; 71(9):2854-61. PubMed ID: 8467463
    [Abstract] [Full Text] [Related]

  • 7. The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia. A comparison of three versus six courses.
    Green DM, Brecher ML, Blumenson LE, Grossi M, Freeman AI.
    Cancer; 1982 Dec 15; 50(12):2722-7. PubMed ID: 6958351
    [Abstract] [Full Text] [Related]

  • 8. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    van Eys J, Berry D, Crist W, Doering E, Fernbach D, Pullen J, Shuster J, Wharam M.
    Cancer; 1989 Jan 01; 63(1):23-9. PubMed ID: 2910421
    [Abstract] [Full Text] [Related]

  • 9. CNS prophylaxis using a triple intrathecal drug therapy without cranial irradiation in acute lymphoblastic leukaemia.
    Asfour I, Misset JL, Mathe G, Sabbour MS.
    Int J Clin Pharmacol Res; 1988 Jan 01; 8(1):47-54. PubMed ID: 3163327
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
    Cáp J, Koza I, Misíková Z, Foltinová A, Strbáková E.
    Neoplasma; 1983 Jan 01; 30(1):81-92. PubMed ID: 6339961
    [Abstract] [Full Text] [Related]

  • 11. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Ochs J, Rivera GK, Pollock BH, Buchanan G, Crist W, Freeman AI.
    Cancer; 1990 Oct 15; 66(8):1671-7. PubMed ID: 2208021
    [Abstract] [Full Text] [Related]

  • 12. Antimetaboliths in the prophylaxis and treatment of central nervous system leukemia.
    Haghbin M.
    Cancer Treat Rep; 1977 Jul 15; 61(4):661-6. PubMed ID: 267507
    [Abstract] [Full Text] [Related]

  • 13. A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study.
    Krance RA, Newman EM, Ravindranath Y, Harris MB, Brecher M, Wimmer R, Shuster JJ, Land VJ, Pullen J, Crist W.
    Cancer; 1991 Feb 01; 67(3):550-6. PubMed ID: 1985748
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP, Turek J, Catania L, Stevenson K, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Neuberg DS, Sallan SE, Silverman LB.
    J Clin Oncol; 2007 Nov 01; 25(31):4914-21. PubMed ID: 17971588
    [Abstract] [Full Text] [Related]

  • 15. Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group study.
    Land VJ, Thomas PR, Boyett JM, Glicksman AS, Culbert S, Castleberry RP, Berry DH, Vats T, Humphrey GB.
    Cancer; 1985 Jul 01; 56(1):81-7. PubMed ID: 3859359
    [Abstract] [Full Text] [Related]

  • 16. Radiotherapy vs intrathecal chemotherapy for CNS prophylaxis in childhood ALL.
    Steinherz PG.
    Oncology (Williston Park); 1989 Sep 01; 3(9):47-53; discussion 58-60. PubMed ID: 2701698
    [Abstract] [Full Text] [Related]

  • 17. Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin.
    Ishii E, Hara T, Ohkubo K, Matsuzaki A, Takeuchi T, Ueda K.
    Med Pediatr Oncol; 1986 Sep 01; 14(2):73-7. PubMed ID: 3458999
    [Abstract] [Full Text] [Related]

  • 18. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM, Shuster JJ, Crist WM, Pullen DJ, Borowitz MJ, Wharam M, Patterson R, Foreman E, Vietti TJ.
    Leukemia; 1992 Jun 01; 6(6):541-6. PubMed ID: 1602793
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Land VJ, Shuster JJ, Crist WM, Ravindranath Y, Harris MB, Krance RA, Pinkel D, Pullen DJ.
    J Clin Oncol; 1994 Sep 01; 12(9):1939-45. PubMed ID: 8083715
    [Abstract] [Full Text] [Related]

  • 20. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
    Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finklestein J, Evans RG, Meyers P, Steinherz LJ, Sather H.
    J Clin Oncol; 1986 May 01; 4(5):744-52. PubMed ID: 3517244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.